Feeling the squeeze?
We are all feeling the impact of increasing prices in our daily lives and business operational costs. Post pandemic staffing is especially challenging for many practices.
Did you know that the average UK vet salary has increased by over 22% since 2019, vet nurse salaries have increased by a similar amount and locums have seen their daily pay increase by over 45%14.
Combining all these rising costs and it’s easy to see why some veterinary practices are starting to feel the squeeze.
The rising cost of missed doses
Are you aware of how much revenue your practice could be losing from clients missing doses?
On average, daily medicines will be dosed over a period of 10%15 more days than a weekly equivalent, due to missed doses.
Over the course of a year, this could result in more than 36 days of missed doses. That is 36 days of missed revenue!
Put that into practice – if you have 15 clients in your care who are receiving daily osteoarthritis medication. For these patients you charge their owner £2.75 per day. Over the course of a year you would have missed over £1,600 in revenue!
Don’t believe us? Use our financial diagnostic tool below and calculate how much revenue you could be missing from your daily OA regime . . .
Are daily treatments the best option for your business and your clients?
Treatment gaps due to dips in plasma levels in daily dosing could increase the risk of your clients pet suffering from OA pain.
Owners may experience OA pain as their pet having ‘off-days’.
8 out of 10 owners say their dog experiences an ‘off day due to OA pain at least once a week’2.
Causes of OA Pain
Missed doses of OA pain relief risk OA pain
Difficulties with owner compliance is a major barrier to consistent treatment of canine OA pain1
VARIABLE PLASMA LEVELS
Variable plasma levels between doses may prevent consistent pain control
58% of vets believe daily dosing makes it difficult to achieve stable/consistent OA pain control2
Over-exercise or natural disease flare-ups risk risk OA pain
90% of vets agree that canine OA pain is variable, often occurring in flare ups2
OA is a progressive disease and if management strategies don’t evolve with this progression, OA pain is a risk
Daxocox® – Weekly OA Pain Relief
Simple weekly dosing with a flavoured tablet
7x less risk of a missed dose, compared with daily dosing
CONSISTENT PLASMA LEVELS
Consistent pain control for 7 days
Daxocox® minimum effective concentration within 24 hours after the 1st “loading dose” and stays at the required therapeutic level for 7 days until the next dose is due5,6
A combination of proven 7-day efficacy with easy weekly dosing of Daxocox® helps to minimise the clinical consequences of unavoidable OA flare-ups
Licensed for all stages of OA
Can be given continuously, with no mandatory treatment breaks1, making Daxocox® a suitable NSAID cornerstone of a responsive multi-modal management approach